PARLIAMENTARY WRITTEN QUESTION
(11 September 2026)
Question Asked
To ask the Secretary of State for Health and Social Care, what assessment she has made of whether the National Institute for Health and Care Excellence's cost-effectiveness methodology adequately reflects the particular circumstances of medicines for rare diseases, including treatments that address an underlying physiological deficiency rather than its symptoms.
Asked by:
Mr Lee Dillon (Liberal Democrat)
Asked by:
Mr Lee Dillon (Liberal Democrat)
Answer
Answered by:
()
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.